Related Experiment Video
Updated: Jul 13, 2026

Human Saphenous Vein Endothelial Cell Isolation and Exposure to Controlled Levels of Shear Stress and Stretch
Published on: April 21, 2023
The association between saphenous vein endothelial function, systemic inflammation, and statin therapy in patients
Aziz Momin1, Narbeh Melikian, Stephen B Wheatcroft
1Cardiovascular Division, King's College London School of Medicine at Guy's, King's College and St Thomas' Hospitals, London, United Kingdom.
Insights
High C-reactive protein levels independently predict reduced saphenous vein endothelial function in coronary artery disease patients, even with statin treatment. Coronary atherosclerotic burden also independently influences C-reactive protein levels.
Area of Science:
- Cardiovascular Medicine
- Vascular Biology
- Inflammation Research
Background:
- Endothelial dysfunction and elevated C-reactive protein (CRP) are key in atherosclerosis and cardiac events.
- Statins are known to reduce CRP and improve endothelial function, but their effect on venous endothelial function is less understood.
- Saphenous veins are commonly used in coronary artery bypass grafting (CABG) surgery.
Purpose of the Study:
- To investigate the association between saphenous vein endothelial function and CRP levels in statin-treated patients undergoing CABG.
- To identify determinants of saphenous vein endothelial function and CRP levels in this patient cohort.
Main Methods:
- Seventy-six patients on statin therapy with optimal LDL cholesterol (<1.6 mmol/L) were studied.
- Saphenous vein endothelial function was assessed ex vivo via acetylcholine-induced relaxation of venous rings.
- Systemic inflammation markers, including C-reactive protein (CRP) and tumor necrosis factor-alpha, were measured.
Main Results:
- Despite statin use, 26% of patients exhibited high-risk CRP levels (>3.0 mg/L).
- A negative linear correlation was observed between acetylcholine-induced venous relaxation and CRP levels (r = -0.30, P = 0.02).
- CRP was the sole independent predictor of saphenous vein endothelial function in multivariate analysis (P = 0.02).
Conclusions:
- In patients with coronary artery disease, CRP level is the independent predictor of saphenous vein endothelial function.
- The extent of coronary atherosclerotic burden independently influences CRP levels.
- Findings highlight the persistent role of inflammation in vascular dysfunction despite statin therapy.
Objectives:
Endothelial dysfunction and C-reactive protein play a pivotal role in development of atherosclerosis and act as markers for future adverse cardiac events. Statins reduce C-reactive protein levels and improve endothelial function. However, little information is available on endothelial function and its determinants in veins. We investigated the association between saphenous vein endothelial function and C-reactive protein levels in patients treated with statins undergoing coronary artery bypass surgery.
Methods:
Seventy-six patients with optimal low-density lipoprotein cholesterol levels (< or =1.6 mmol/L) secondary to regular treatment with a minimum of simvastatin 40 mg were recruited. Each subject underwent detailed characterization according to anthropomorphic data, saphenous vein endothelial function (assessed ex vivo by measuring acetylcholine-induced relaxation of venous rings), and markers of systemic inflammation (C-reactive protein and tumor necrosis factor-alpha).
Results:
Despite regular treatment with statins, 26% of patients had C-reactive protein levels in the "high-risk" range (>3.0 mg/L). There was a negative linear correlation between acetylcholine-induced venous relaxation and C-reactive protein (r = -.30, P = .02) and waist circumference (r = -0.21, P = .03). In a multivariate regression model, C-reactive protein (P = .02) was the only independent predictor of acetylcholine-induced venous relaxation. In turn, correlates of C-reactive protein were assessed. There was a correlation between C-reactive protein and coronary atherosclerotic burden (r = .46, P < .0001), body mass index (r = .26, P = .03), fasting glucose levels (r = .31, P = .01), and waist circumference (r = .29, P = .01). Using multivariate analysis, coronary atherosclerotic burden (P < .0001) was the only independent predictor of C-reactive protein.
Conclusions:
In our cohort of patients with coronary artery disease, C-reactive protein level was the only independent predictor of saphenous vein endothelial function. In turn, its levels were independently influenced by the extent of coronary atherosclerotic burden.
More Related Videos
08:05Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
09:04Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg
Published on: November 19, 2019
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Atherosclerosis III: Management
Peripheral Artery Disease I: Introduction
Peripheral Artery Disease IV: Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction